13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2019-12-31, filed 2020-02-14, with 40 holding rows worth $405,673,000.
- Accession
- 0001172661-20-000519
- Filer
- CIK 1792126
- Filed
- 2020-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2019
A holdings report, 40 entries on the cover page, a total value of $405,673,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $405,673,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 253,660 | $32,687,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 226,002 | $29,163,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 210,000 | $27,061,000 | thousands by filing date | put |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 200,000 | $25,772,000 | thousands by filing date | call |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 179,898 | $25,027,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 962,553 | $20,637,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 587,108 | $17,977,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 204,420 | $17,938,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 389,153 | $17,691,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 231,009 | $16,837,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 287,024 | $14,963,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 267,676 | $14,192,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 190,150 | $13,727,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 124,937 | $12,913,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 55,700 | $11,387,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 187,242 | $10,193,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 3,322,816 | $10,002,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 138,425 | $9,920,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 186,238 | $7,366,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 1,350,351 | $6,117,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 220,543 | $6,105,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 134,397 | $5,173,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 223,337 | $5,083,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 101,050 | $4,760,000 | thousands by filing date | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 339,900 | $4,754,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 523,462 | $4,491,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 114,411 | $4,366,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 188,000 | $3,846,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 424,618 | $3,227,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 39,647 | $2,987,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 523,803 | $2,970,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 1,145,528 | $2,841,000 | thousands by filing date | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 27,279 | $2,485,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 613,999 | $2,476,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 86,591 | $2,276,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 123,635 | $2,057,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 227,835 | $1,620,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 212,449 | $1,594,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 40,529 | $499,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 122,931 | $493,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-20-000519 | this filing | 2020-02-14 | acceptance time not in the bulk data set |